Meeting Minutes-DSTU-Testing Team 8-26-2010
Return to main RPS R2 DSTU Technical Team Page
Matthew Lukela, Regeneron; Aaron Grant, Liquent; Mary Padgett, FDA; Joel Finkle, ISI; Ragu Pathmanathan, Abbott; Jill Geist, Abbott; Scott Becker, Merck; Bernadette Billet, Liquent
The main focus of this meeting was to discuss criteria for evaluating the RPS messages being created based on the test case team Phase 1 scenarios. A draft document outlining the main focus of each test case and the RPS-specific components to each message was presented to use as the basis for the message comparison/analysis. Results and discussions that take place during the XML message review will be captured directly in the document. The team agreed that this approach is appropriate. The document will be posted on gForge and notification sent to the listserve of its availability for review.
The next technical team meeting is schedule for September 9, at which time the sample messages created to date will be reviewed so that any different interpretations can be discussed and resolved. The findings that result from this meeting will be presented to the full DSTU team at the September 14 meeting.
Copyright © Health Level Seven International ® ALL RIGHTS RESERVED. The reproduction of this material in any form is strictly forbidden without the written permission of the publisher.